LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing
Series B co-led by Fast Track Initiative, DCI Partners, and 4BIO Capital Proceeds to accelerate development of LUCA’s novel Mitochondria Isolation Technology (MIT) platform, IND-enabling activities for its in-house pipeline and establish its manufacturing capability LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutical......
